Barclays initiated coverage on Guardant Health with a new price target
$GH
Medical Specialities
Health Care
Barclays initiated coverage of Guardant Health with a rating of Overweight and set a new price target of $60.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/10/2025 | $55.00 | Outperform | Mizuho |
| 1/23/2025 | $60.00 | Overweight | Barclays |
| 6/28/2024 | $36.00 | Neutral → Buy | Guggenheim |
| 6/3/2024 | $32.00 | Buy | Jefferies |
| 4/24/2024 | $28.00 | Buy | Craig Hallum |
| 12/14/2023 | Neutral | Guggenheim | |
| 12/13/2023 | Peer Perform | Wolfe Research | |
| 11/13/2023 | $27.00 | Mkt Perform → Outperform | Raymond James |